Related Experiment Video
Updated: May 11, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
[Research in pediatric hematology [Germany, 1970-2000]]
1Abteilung für Molekulare Hämatopoese, Kinderklinik, Medizinische Hochschule Hannover, Hannover, Germany. Welte.Karl.H@mh-hannover.de
Abstract:
Professor Riehm was not only an excellent pediatric oncologist, but also an excellent hematologist. He was a mentor also for young scientists who were interested in hematological research as his/her main focus. In the 1970s he has promoted research in coagulation disorders, during 1980s he supported the investigation on hematopoetic growth factors. During the 1990 s he was one of the first in Europe who have used hematopoietic growth factors as a supportive therapy in the protocol ALL-BFM and has also helped to set up the International Registry for Severe Chronic Neutropenias [SCNIR] in his Department. The sense of the top research directions of the time distinguishes him not only as a pioneer of the leukaemia therapy studies, but also as a pioneer in hematology. He created the environment in which research could blossom.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Regulation of Hematopoietic Stem Cells
Pharmacokinetics in Pediatric Patients: Drug Distribution
Hematopoiesis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
